Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-230727 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
553
Total Value
$579.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer and EVP | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 238 | โ | โ | 7,915 | Direct | โ | View Details | |
Chief Scientific Officer and EVP | Common Stock | โ | May 18, 2026 | Sale | 77 | $7.53 | $579.81 | 7,838 | Direct | โ | View Details | |
Chief Scientific Officer and EVP | Restricted Stock Units | Derivative | May 15, 2026 | Exercise/Conversion | 141 | $0.00 | $0.00 | 422 | Direct | โ | View Details | |
Chief Scientific Officer and EVP | Restricted Stock Units | Derivative | May 15, 2026 | Exercise/Conversion | 97 | $0.00 | $0.00 | 683 | Direct | โ | View Details |